FOLH1 and posterior cortical atrophy: Various PSMA-targeting radioligands were developed in recent years, whereof 68Ga-PSMA-11 has emerged as the current “gold standard” for PET imaging of PCa patients with biochemical recurrence and for re-staging of the disease after therapy 10-13.